Early research (Phase 1)Study completedNCT00002765What this trial is testingImmunotoxin in Treating Patients With Leukemia or LymphomaWho this might be right forLeukemiaLymphoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT05702853What this trial is testingMetabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLLWho this might be right forB-cell Non Hodgkin LymphomaChronic Lymphocytic Leukemia Medical University of South Carolina 27
Early research (Phase 1)UnknownNCT00769613What this trial is testingEmergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsWho this might be right forCancer Milton S. Hershey Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01994382What this trial is testingPhase 1/2a Dose Escalation Study in Participants With CLL, SLL, or NHLWho this might be right forFollicular Lymphoma (FL/Indolent NHL)Aggressive NHL (a NHL)Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)+2 more Alexion Pharmaceuticals, Inc. 260
Not applicableStudy completedNCT00445952What this trial is testingNatural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 304
Large-scale testing (Phase 3)Study completedNCT00666211What this trial is testingOpioid Titration Order Sheet or Standard Care in Treating Patients With Cancer PainWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more Vanderbilt-Ingram Cancer Center 98
Early research (Phase 1)Study completedNCT01567709What this trial is testingAlisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell LymphomaWho this might be right forAdult B Acute Lymphoblastic LeukemiaAdult T Acute Lymphoblastic LeukemiaAnaplastic Large Cell Lymphoma+32 more National Cancer Institute (NCI) 34
Testing effectiveness (Phase 2)Study completedNCT00110045What this trial is testingCaspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell TransplantWho this might be right forCancer European Organisation for Research and Treatment of Cancer - EORTC 171
Not applicableWithdrawnNCT00378781What this trial is testingHeparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related InfectionWho this might be right forCancer M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00079378What this trial is testingDecitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more National Cancer Institute (NCI) 84
Testing effectiveness (Phase 2)Study completedNCT00448201What this trial is testingReduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more UNC Lineberger Comprehensive Cancer Center 71
Testing effectiveness (Phase 2)UnknownNCT00003885What this trial is testingArsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or MyelomaWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Our Lady of Mercy Medical Center 60
Not applicableStudy completedNCT00716911What this trial is testingMeasuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell TransplantWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more City of Hope Medical Center 100
Large-scale testing (Phase 3)Study completedNCT00003816What this trial is testingCombination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more Roswell Park Cancer Institute 361
Early research (Phase 1)WithdrawnNCT00521261What this trial is testingDonor T Cells, Low-Dose Aldesleukin, and Low-Dose GM-CSF After Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forLymphoma Barbara Ann Karmanos Cancer Institute
Large-scale testing (Phase 3)Study completedNCT00750009What this trial is testingPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialWho this might be right forBrain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+6 more Case Comprehensive Cancer Center 583
Early research (Phase 1)Ended earlyNCT01116154What this trial is testingVorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+28 more City of Hope Medical Center 30
Not applicableStudy completedNCT00534118What this trial is testingDonor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell TransplantWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more Roswell Park Cancer Institute 39
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Active Not RecruitingNCT04007029What this trial is testingModified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forCD19 PositiveCD20 PositiveRecurrent Chronic Lymphocytic Leukemia+11 more Jonsson Comprehensive Cancer Center 24